Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: a bedside-to-bench approach

Autor: Rasmus R. Mikkelsen, Malthe P. Hundahl, Christopher K. Torp, Javier Rodríguez-Carrio, Mads Kjolby, Jens M. Bruun, Tue W. Kragstrup

Publikováno v: Scopus
Mikkelsen, R R, Hundahl, M P, Torp, C K, Rodríguez-Carrio, J, Kjolby, M, Bruun, J M & Kragstrup, T W 2022, ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ', European Journal of Pharmacology, vol. 925, 174998 . https://doi.org/10.1016/j.ejphar.2022.174998

OBJECTIVE: To assess which immunosuppressive drugs have been investigated and proven efficacious in patients with cardiovascular disease (CVD) or type 2 diabetes (T2D) without preexisting immune mediated disorders to validate in vitro and animal mode

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f756fa0c7d520da4cd8a98288ea820d
http://hdl.handle.net/10651/65535